Details for New Drug Application (NDA): 217115
✉ Email this page to a colleague
The generic ingredient in VARENICLINE TARTRATE is varenicline tartrate. There is one drug master file entry for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
Summary for 217115
| Tradename: | VARENICLINE TARTRATE |
| Applicant: | Piramal |
| Ingredient: | varenicline tartrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 217115
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG BASE | ||||
| Approval Date: | Jul 23, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
| Approval Date: | Jul 23, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
